Literature DB >> 31036990

Monitoring Protocols for Cochlear Toxicity.

Sherman G Lord1.   

Abstract

The need for monitoring hearing and auditory function during drug therapy and other treatments that have the potential to cause hearing loss is well documented. Besides the main purpose of ototoxic monitoring, which is to provide feedback to the attending physician about the effects the treatment is having on the auditory system, it is also helpful in setting expectations for the patient and his/her family about the communication issues that may result from the drug therapy. This article will review tests available to an audiologist, both subjective and objective, that can be used to effectively monitor hearing levels and auditory function during treatment. Published guidelines and various ototoxic monitoring protocols are reviewed regarding tests administered, what constitutes a significant change in test results and how these findings are reported, and the impact significant changes may have on the course of treatment. Test protocols from different institutions are compared for both similarities and contrasts. Effective scheduling and test location are key to a successful monitoring program. Finally, the need to streamline ototoxic monitoring of hearing and auditory function to reduce test time and make it less stressful and tiresome on the patient will be considered.

Entities:  

Keywords:  distorting product otoacoustic emissions; extended high-frequency audiometry; ototoxic monitoring program; ototoxicity

Year:  2019        PMID: 31036990      PMCID: PMC6486360          DOI: 10.1055/s-0039-1684042

Source DB:  PubMed          Journal:  Semin Hear        ISSN: 0734-0451


  27 in total

1.  Placement of vibrator in bone-conduction testing.

Authors:  G A STUDEBAKER
Journal:  J Speech Hear Res       Date:  1962-12

2.  Distortion-product otoacoustic emission test performance for ototoxicity monitoring.

Authors:  Kelly M Reavis; Garnett McMillan; Donald Austin; Frederick Gallun; Stephen A Fausti; Jane S Gordon; Wendy J Helt; Dawn Konrad-Martin
Journal:  Ear Hear       Date:  2011-02       Impact factor: 3.570

Review 3.  Genetic factors in aminoglycoside toxicity.

Authors:  Nathan Fischel-Ghodsian
Journal:  Pharmacogenomics       Date:  2005-01       Impact factor: 2.533

4.  Hearing loss--risk factor for cisplatin ototoxicity? Observations.

Authors:  J D Durrant; G Rodgers; E N Myers; J T Johnson
Journal:  Am J Otol       Date:  1990-09

5.  Early changes in auditory function as a result of platinum chemotherapy: use of extended high-frequency audiometry and evoked distortion product otoacoustic emissions.

Authors:  Kristin R Knight; Dale F Kraemer; Christiane Winter; Edward A Neuwelt
Journal:  J Clin Oncol       Date:  2007-04-01       Impact factor: 44.544

Review 6.  Global problem of drug-induced hearing loss.

Authors:  E Arslan; E Orzan; R Santarelli
Journal:  Ann N Y Acad Sci       Date:  1999-11-28       Impact factor: 5.691

Review 7.  Platinum-induced ototoxicity in children: a consensus review on mechanisms, predisposition, and protection, including a new International Society of Pediatric Oncology Boston ototoxicity scale.

Authors:  Penelope R Brock; Kristin R Knight; David R Freyer; Kathleen C M Campbell; Peter S Steyger; Brian W Blakley; Shahrad R Rassekh; Kay W Chang; Brian J Fligor; Kaukab Rajput; Michael Sullivan; Edward A Neuwelt
Journal:  J Clin Oncol       Date:  2012-04-30       Impact factor: 44.544

Review 8.  Hearing health and care: the need for improved hearing loss prevention and hearing conservation practices.

Authors:  Stephen A Fausti; Debra J Wilmington; Patrick V Helt; Wendy J Helt; Dawn Konrad-Martin
Journal:  J Rehabil Res Dev       Date:  2005 Jul-Aug

9.  Factors affecting sensitivity of distortion-product otoacoustic emissions to ototoxic hearing loss.

Authors:  Kelly M Reavis; David S Phillips; Stephen A Fausti; Jane S Gordon; Wendy J Helt; Debra Wilmington; Gene W Bratt; Dawn Konrad-Martin
Journal:  Ear Hear       Date:  2008-12       Impact factor: 3.570

10.  Comparison of ABR stimuli for the early detection of ototoxicity: conventional clicks compared with high frequency clicks and single frequency tonebursts.

Authors:  Stephen A Fausti; Christopher L Flick; Alison M Bobal; Roger M Ellingson; James A Henry; Curtin R Mitchell
Journal:  J Am Acad Audiol       Date:  2003-07       Impact factor: 1.664

View more
  5 in total

1.  Cisplatin-associated ototoxicity: perspectives from a single institution cervical cancer cohort and implications for developing a locally responsive monitoring programme in a public healthcare setting.

Authors:  Jessica Paken; Cyril D Govender; Mershen Pillay; Vikash Sewram
Journal:  BMC Health Serv Res       Date:  2022-06-18       Impact factor: 2.908

2.  Adverse Audio-Vestibular Effects of Drugs and Vaccines Used in the Treatment and Prevention of COVID-19: A Review.

Authors:  Magdalena B Skarzynska; Monika Matusiak; Piotr H Skarzynski
Journal:  Audiol Res       Date:  2022-04-29

Review 3.  Hearing Loss in Beta-Thalassemia: Systematic Review.

Authors:  Immacolata Tartaglione; Roberta Carfora; Davide Brotto; Maria Rosaria Barillari; Giuseppe Costa; Silverio Perrotta; Renzo Manara
Journal:  J Clin Med       Date:  2021-12-25       Impact factor: 4.241

Review 4.  Prevention of Noise-Induced Hearing Loss Using Investigational Medicines for the Inner Ear: Previous Trial Outcomes Should Inform Future Trial Design.

Authors:  Colleen G Le Prell
Journal:  Antioxid Redox Signal       Date:  2021-10-04       Impact factor: 7.468

5.  What Are the Current Audiological Practices for Ototoxicity Assessment and Management in the South African Healthcare Context?

Authors:  Katijah Khoza-Shangase; Nothando Masondo
Journal:  Int J Environ Res Public Health       Date:  2020-04-10       Impact factor: 3.390

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.